Sort
261,768 grants matching “gene therapy”
Neurovascular and metabolic sex differences in contributions to cognitive impairment and dementia including Alzheimer's disease
$2,581,762Bistra Iordanova · University Of Pittsburgh At Pittsburgh · RF1 · FY2020 · NS
Epidemiology and Natural History of Cancer-Associated Viruses
$2,581,642Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Pathobiology of Neurodegeneration in C9ORF72 repeat expansion
$2,581,235Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2024 · NS
The Molecular Drivers and Therapeutic Susceptibilities in Lineage State Transitions of Metastatic Prostate Cancer
$2,579,971Joshua Michael Lang · University Of Wisconsin-Madison · P01 · FY2025 · CA
SPORE in Lung Cancer
$2,579,831University Of Pittsburgh At Pittsburgh · P50 · FY2002 · CA
Immunopathogenesis of Fungal Infections
$2,579,234Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Cellular And Synaptic Physiology Of Hippocampal Interneurons
$2,579,011Christopher McBain · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Data and Analysis Core
$2,578,891Matthew Douglas Johnson · University Of Minnesota · U54 · FY2024 · AT
Novel Strategies to Improve Blood Transfusion Practice
$2,578,863Hongbo R Luo · Brigham And Women'S Hospital · P01 · FY2025 · HL
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
$2,578,594James E Crowe · University Of Texas Med Br Galveston · U19 · FY2021 · AI
Harvard PRECISION Human Pain Center
$2,578,553William Russell Renthal · Brigham And Women'S Hospital · U19 · FY2023 · NS
Discovery and validation of novel targets for pharmacotherapy of alcoholism
$2,578,533Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA
Skeletal Disorders and Mineral Homeostasis Section
$2,578,134Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Metabolic determinants of Mtb virulence, vulnerability and variation
$2,578,114David Branch Moody · Brigham And Women'S Hospital · U19 · FY2022 · AI
Cell and Gene Therapy for Nonmalignant Blood Disorders
$2,578,045Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2017 · HL
Novel Cord Blood-Derived Cellular Therapies
$2,576,646Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Risk Factors for Onset and Persistence of TMD
$2,575,925William Maixner · Univ Of North Carolina Chapel Hill · U01 · FY2007 · DE
SPORE in Prostate Cancer
$2,575,818Mayo Clinic Coll Of Medicine, Rochester · P50 · FY2002 · CA
Depression, Biobehavioral Mechanisms, & CHD/Mortality Outcomes
$2,575,728Karina W. Davidson · Columbia University Health Sciences · P01 · FY2012 · HL
Novel Therapies for Muco-Obstructive Lung Diseases
$2,575,240Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2014 · HL
ETIB Clinical Trials
$2,575,229Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Molecular Targeting of Developmental Cancers in Children
$2,575,193Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,574,738Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA
Harvard PRECISION Human Pain Center
$2,574,551William Russell Renthal · Brigham And Women'S Hospital · U19 · FY2024 · NS
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,573,891Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI